Actigraphy for sleep/wake assessment (coverage criteria)
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines Blue Cross Blue Shield - Rhode Island coverage stance on use of actigraphy to record and analyze body movement for evaluation of sleep disorders and related indications for both Medicare and commercial products.
No material clinical or coverage changes in this revision.
Coverage criteria for actigraphy
Coverage determination
Covered when ALL of the following are met:
Applies to BlueCHiP for Medicare and Commercial Products as stated.
See statements that component use should not be separately reported.
Regulatory clearance does not imply coverage; clinical validity concerns cited.
Actigraphy when used as the sole technique to record and analyze body movement — including for the evaluation of sleep disorders — is not covered / not medically necessary. This applies across product lines as stated for BlueCHiP for Medicare and Commercial Products. When actigraphy is incorporated as a component of portable sleep monitoring, that component use is not excluded from coverage but should not be separately reported.
For Commercial products, actigraphy used as the sole technique to record and analyze body movement to evaluate sleep disorders is considered not medically necessary. CPT code 95803 (Actigraphy testing, recording, analysis, interpretation and report) is listed as not medically necessary/not covered; when billed, verify group/contract benefits and Evidence of Coverage for applicable coverage determinations.
Coding and billing guidance
| 95803 | Actigraphy testing, recording, analysis, interpretation and report (minimum of 72 hours to 14 consecutive days of recording) |
Provider actions, billing rules, and denial triggers
Prior authorization
Not applicable
Provider action
Actigraphy is considered not covered when used as the sole technique to record and analyze body movement, including but not limited to its use to evaluate sleep disorders. This does not include the use of actigraphy as a component of portable sleep monitoring.
- When used as a component of portable sleep monitoring, actigraphy should not be separately reported.
Billing rule
When used as a component of portable sleep monitoring, actigraphy should not be separately reported.
Denial triggers
Actigraphy used as the sole technique to record and analyze body movement (including for evaluation of sleep disorders) is considered not medically necessary / not covered. The following code is not medically necessary/not covered: 95803 — Actigraphy testing, recording, analysis, interpretation and report (minimum of 72 hours to 14 consecutive days of recording). Benefits may vary by group/contract; refer to Evidence of Coverage or Subscriber Agreement.
- Denial trigger: Use of actigraphy as the sole diagnostic technique.
- Not medically necessary / not covered code: 95803.
Background and context
Actigraphy refers to the assessment of activity patterns using devices typically placed on the wrist or ankle that record body movement; algorithms interpret those movements to estimate periods of sleep and wake. Devices may be used to assess circadian rhythm disorders, insomnia, hypersomnolence, and activity levels, but actigraphy has known limitations compared with polysomnography, particularly in distinguishing sleep from wake in individuals with disturbed sleep.
Numerous actigraphy devices have received U.S. Food and Drug Administration (FDA) clearance for marketing through the 510(k) process, and recordings commonly span multiple days. Per coding guidance, actigraphy testing described by CPT code 95803 specifies a recording duration of a minimum of 72 hours to 14 consecutive days.
Because actigraphy provides an indirect measure of sleep through movement, its clinical utility varies by indication and it is not accepted as a standalone diagnostic substitute for polysomnography in the evaluation of sleep disorders; policy reflects that standalone use is not covered while component use within portable monitoring is allowable but should not be billed separately.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.